Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.

Criscitiello, C

Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Apr 2014 - 910-911 p. digital

Publication Type: Letter; Comment

1569-8041

10.1093/annonc/mdu034 doi


Breast Neoplasms--drug therapy
Female
Humans
Mastectomy, Segmental
Neoadjuvant Therapy
Receptor, ErbB-2--metabolism